Mason & Associates (California)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,107
Closed -$210K 120
2024
Q4
$210K Buy
2,107
+75
+4% +$7.73K 0.05% 104
2024
Q3
$231K Buy
2,032
+3
+0.1% +$356 0.06% 104
2024
Q2
$251K Buy
2,029
+2
+0.1% +$258 0.07% 93
2024
Q1
$268K Sell
2,027
-18
-0.9% -$2.22K 0.07% 91
2023
Q4
$223K Buy
+2,045
New +$212K 0.07% 80
2023
Q3
Sell
-1,838
Closed -$212K 89
2023
Q2
$212K Buy
+1,838
New +$209K 0.06% 84

Other funds holding MRK

Mason & Associates (California)'s MRK Position: Q1 2025 in Review

Mason & Associates (California) sold out of Merck (MRK) in Q1 2025, closing a stake of 2,107 shares — an estimated $210K sold.

Mason & Associates (California) first reported a position in MRK in Q2 2023 and held it in 6 quarters. The position peaked at $268K in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Mason & Associates (California) reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Mason & Associates (California) sold 2,107 Merck shares in Q1 2025, an estimated $210K.
  • Mason & Associates (California) first reported a position in Merck in Q2 2023 and held it in 6 quarters.
  • Mason & Associates (California)'s Merck position peaked at $268K in Q1 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Mason & Associates (California)'s 13F filing for Q1 2025, filed 17 Apr 2025.